Determination of cardiovascular risk and vascular age by the Framingham score in patients at the Arzobispo Loayza Hospital

Authors

DOI:

https://doi.org/10.24265/horizmed.2015.v15n2.05

Keywords:

Cardiovascular risk, Vascular age, Cardiovascular disease, Framingham score

Abstract

Cardiovascular diseases rank fourth place of disease burden in Peru, and in the last 7 years, the population of high cardiovascular risk has increased. Objective: Determine the cardiovascular risk and vascular age according to the Framingham score in patients attending the "Hospital Nacional Arzobispo Loayza", as well as to determine the most prevalent factor. Furthermore, to determine the clinical characteristics of patients with mild and high risk. Material and Methods: This is a descriptive, observational, cross-sectional study. 238 hospitalized patients in internal medicine wards were surveyed. Variables such as age, gender, diabetes, smoking, BMI and blood pressure were considered. The data were analyzed using SPSS v.21. Results: The highest percentage of the population was found within the mild and high risk categories, with diabetes being the most prevalent factor. The average difference between chronological age and vascular age was 6.9 years. Conclusion: The majority of the population has mild and high risk, thus primary and secondary prevention measures should be taken.

Downloads

Download data is not yet available.

References

World Health Organization. Global status report on non- communicable diseases 2010. Geneva: WHO; 2011.

Organización Mundial de la Salud. Estadísticas Sanitarias Mundiales 2014. Ginebra: OMS; 2014

Castillo I, Armas NB, Dueñas A, González OR, Arocha C, Castillo. Riesgo cardiovascular según tablas de la OMS, el estudio Framingham y la razón apolipoproteína B/apolipoproteína A1. Revista Cubana de Investigaciones Biomédicas. 2010; 29:479-88.

D'Agostino RB, Sr., Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008; 117(6):743-53.

Ruiz E, Segura L, Agusti R. Uso del score de Framingham como indicador de los factores de riesgo de las enfermedades cardiovasculares en la población peruana. Rev Per Card. Setiembre - Diciembre 2012; 38(3): 1-19

Guerreros A, Matsuno A, Ruiz E, Farias C. Guía Nacional de Abordaje al Tabaquismo Perú 2010. 1era Ed; Perú 2010

Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M et al Guía europea sobre prevención de la enfermedad cardiovascular en la práctica clínica (versión 2012) .Rev Esp Card. 2012;65:937. e1-e66

Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VII)

Guías de la asociación americana de diabetes (ADA) para diagnóstico y tratamiento de la Diabetes Mellitus 2014

Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010;363:2211-9

Gerin W, Schwartz AR, Schwartz JE, Pickering TG, Davidson KW, Bress J, et al. Limitations of current validation protocols for home blood pressure monitors for individual patients. Blood Press Monit. 2002; 7: 313-318.

D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General Cardiovascular Rosk Profile for use in PrimarCare:. The Framingham Heart Study. Circulation. 2008;117:743-73 Disponible en: http://www.framinghamheartstudy.org/risk-functions/cardiovascular-disease/10-year-risk.php

lcaza G, Núñez L, Marrugat J, Mujica V, Escobar MC, Jiménez AL, et al. Estimación de riesgo de enfermedad coronaria mediante la función de Framingham adaptada para la población chilena. Revista médica de Chile. 2009; 137:1273-82.

Ruiz E. Riesgo y prevención cardiovascular. 1º ed. Lima: Unigraph; 2014.

Howard B, Best L, Galloway J, James W, Jones K, Lee E, et al. Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors. Diabetes Care. 2006; 29:391-7.

B M Champagne, E M Sebrié, H Schargrodsky, P Pramparo, C Boissonnet, E Wilson. Tobacco smoking in seven Latin American cities: the CARMELA study. Tob Control [revista en Internet] 2010 [acceso 23 Junio 2014];19(6); 457-462 Disponible en: http://tobaccocontrol.bmj.com/content/19/6/457.long

Dueñas, A. Riesgo cardiovascular total en los trabajadores del Hotel "Meliá Cohíba. Rev Cubana Endocrinol [revista en Internet]. 2008 [acceso 23 Junio 2014]; 19(1); Disponible en: http://scielo.sld.cu/scielo.php?pid=S1561-29532008000100003&script=sci_arttext

Masson W, Siniawski D, Toledo G, Vita T, Fernández G, Del Castillo S y cols. Estimación de la «edad vascular» basada en el índice de masa corporal en una población en prevención primaria. Asociación con la aterosclerosis carotídea subclínica. Med Clin (Barc). 2013; 140(6):255-259

Published

2015-06-25

How to Cite

1.
Mayta Calderón JC, Morales Moreno AM, Cárdenas Rojas AD, Mogollón Lavi J Ángella, Armas Rodríguez V, Neyra Arismendiz L, Ruíz Mori CE. Determination of cardiovascular risk and vascular age by the Framingham score in patients at the Arzobispo Loayza Hospital. Horiz Med [Internet]. 2015Jun.25 [cited 2025May2];15(2):27-34. Available from: https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/277

Issue

Section

Original article